ABSTRACT. Serological survey of bovine immunodeficiency virus (BIV) and bovine leukemia virus (BLV) infection was conducted in dairy cattle from 10 different regions of Hokkaido, Japan. Among 390 cattle, 11.0% of cattle were BIV-seropositive and 3.3% were BLV-seropositive. Moreover, in two dairy farms, where bovine leukosis has been reported, prevalence of BIV infections were 6.4 and 9.1%, respectively. In contrast, among 150 beef cattle, 16.6% were BIV-seropositive while none was BLV-seropositive. Dual infections with BLV and BIV in dairy cattle were tested by using 107 BLV-seropositive sera, and 20 sera were found BIV-positive (18.7%). These results indicate that BIV infection was widespread in Hokkaido. KEY WORDS: bovine immunodeficiency virus, bovine leukemia virus, seroepidemiological survey.
Bovine immunodeficiency virus (BIV), a member of the lentivirus subfamily of retroviruses, was originally isolated from a dairy cow with persistent lymphocytosis, lymphoid hyperplasia, and perivascular cuffing in brain [24] . BIV shares many serological and genetic features with other lentiviruses, including human, feline, and simian immunodeficiency viruses [6, 7] . Since its recognitions as a lentivirus in the late 1980s, seroepidemiological evidence indicates that BIV infection has a worldwide distribution. Serological surveys have shown the presence of seropositive cattle in the USA [23] , Canada [11] , the Netherlands [10] , New Zealand [9] , Germany [17] , France [20] , Great Britain [21] , Japan [12] , Costa Rica [8] , Italy [3] , Australia [5] , Korea [4] , in water buffalo in Pakistan [15] , in draught animal in Cambodia [13] , Indonesia [1] and Brazil [14] . However, conclusive evidence that BIV causes immunodeficiency in cattle has not been established.
Although several pathological changes have been reported in BIV-infected cattle, including monocyte dysfunction [18] , encephalophathy and lymphadenophathy [24] , the detailed pathogenesis of BIV in infected cattle still remains unclear. BIV seropositivity has been shown to be variably associated with decrease in animal production, weight loss, secondary diseases, and diminished milk production [11] , but there has been no demonstration that BIV plays a direct role in clinical diseases of naturally infected cattle. In many cases, such a demonstration is complicated by the presence of confounding factors including co-infection with bovine leukemia virus (BLV), which can cause lymphoid tumors and persistent lymphocytosis in its host though most of infected cattle remain clinically and hematologically normal [2] .
Information on the correlation between BIV and BLV infections is still limited in Japan. In this short communication, additional surveys of BIV and BLV were conducted in dairy and beef cattle herds in some districts where there were no previous reports in Hokkaido. Following serum samples were collected during the period of 1998-2000. All these sera were stored at -20°C until further use. A total of 390 sera were randomly collected from 10 districts (271 dairy herds) in Hokkaido. Serum samples were also collected from two different dairy farms near Sapporo area (Farm I and II consisting of 44 and 109 cattle, respectively) where bovine leukosis has been reported. In order to determine dual infection of BLV and BIV, 107 BLV-seropositive sera from dairy cattle (Kamikawa area) were tested for prevalence of BIV infection. Similarly, 150 sera of beef cattle (Japanese black cattle) in the Tokachi area were also collected.
Anti-BIV and -BLV antibodies were detected in those sera by Western blot analysis using the BIV gag protein, p26 [12] [13] [14] [15] [16] , and immunodiffusion test using the BLV glycoprotein (gp51) antigen as described by Onuma et al. [19] , respectively. As summarized in Table 1 , the prevalence of BIV in dairy cattle from each district ranged from 0.0 to 25.0% (average 11.0%), whereas BLV ranged from 0.0 to 13.3% (average 3.3%). These data indicate that BIV-infection is more common than BLV-infection in cattle, and only one cow in the Kushiro district is positive for both BIV and BLV. An additional study on the BIV-prevalence of other two farms, where bovine leukosis has been reported, identified 4 BIV-seropositive (9.1%) and 16 BLV-seropositive cattle (36.4%), and 2 cattle (4.5%) seropositive for both BIV and BLV in Farm I (Table 2) . In Farm II, 7 BIV-seropositive (6.4%) and 10 BLV-seropositive cattle (9.2%), and 2 cattle (1.8%) seropositive for both BIV and BLV were identified. Out of 107 BLV-seropositive samples from some dairy herds, 20 cattle (18.7%) were found to be BIV-seropositive. Moreover, among 150 beef cattle from the Tokachi area, 25 cattle (16.6%) were BIV-seropositive and none was positive for BLV.
In order to confirm BIV infection on BIV-seropositive cattle, 13 blood samples were randomly collected from BIV-seropositive cattle. Peripheral blood mononuclear cells (PBMCs) were separated by the Ficoll-Conray gradient centrifugation method. Then, total cellular DNA was extracted from PBMCs by the phenol-chloroform method, and nested PCR was performed to detect the BIV proviral DNA, as described earlier [12, 14] . The first amplification was done by using a pair of the outer primers specific to the BIV pol region (nt 2129-2148: 5'-GTATCAGGCTCT-TAAGGAAA-3', and nt 2541-2522: 5'-TAATCT-TCTGGGTGGTAGTC-3'). The second amplification was performed to amplify a 298 bp fragment, using a pair of inner primers of pol region (nt 2181-2220: 5'-TCCGAAGCTGCTTGGGATAA-3', and nt 2479-2460: 5'-TTCCACTGGAACCTCTCTAT-3') in the BIV genome [6, 12, 13] . The amplified products were fractionated on a 2.0% agarose gel, and visualized by the staining with ethidium bromide. As shown in Fig. 1 , BIV-specific 298-bp fragments corresponding to the part of the pol region were detected in the 12 samples prepared from 13 seropositive cows. Amplified products had been previously confirmed to be BIV-specific by Southern hybridization and sequence analysis [12] [13] [14] , and these confirmations were not repeated in the present study.
Data of this study provide an additional information on the seroprevalence of BIV in Japanese cattle. We have shown that BIV infection in dairy cattle was widespread at least on 9 out of 10 districts in Hokkaido (Table 1 ) and the prevalence rate was not so high as compared to other area in our previous studies [12] [13] [14] . However, other studies revealed that the rates of BIV detection ranges from 1.4 to 80% depending on the methods of detection and source of samples [1-5, 8-11,15, 17, 20, 21, 23] .
The impact of BIV infection on the health status of field herds is not known, although serological evidence for BIV infection has been reported in many countries around the world. However, it has been suggested that BIV infection is associated with decreased milk production in dairy cattle [11] , secondary bacterial infection, stressor of parturition and early lactation and/or with unusual environmental stress as cofactors in a Louisiana dairy cattle herd [21] . Thus, information obtained by the surveillance of BIV and BLV infection would be important for cattle industry in Hokkaido and other areas in Japan.
The mechanisms of transmission of BIV are not clearly defined, but the high incidences of BIV-infected cattle in some dairy herds suggest the presence of efficient mode of transmission. Recently, we found that BIV can be transmitted to offspring in utero, and that BLV can be transmitted through colostrum or milk if dams are infected with both BLV and BIV in dairy cattle herds [16] . In two dairy herds (Farm I and II), where enzootic bovine leukosis has been reported, the rates of dual infection of BLV and BIV were 4.5 and 1.8%, respectively (Table 2) . Moreover, relatively higher percentage of BIV infection (18.7%) was found in BLV-infected cattle, compared to 11.0% for BIV infection in randomly collected samples where 3.3% was positive for BLV. Thus, there is a possibility that BIV-seropositivity seems to be increased in BLV-infected cattle. However, a larger scale of serological and molecular biological studies with detailed long term epidemiological observation of BIV-incidences will be necessary to confirm these preliminary findings, and the role of BIV in diseases progression in cattle has to be elucidated.
In conclusion, seroprevalence of BIV in healthy dairy cattle herds in Hokkaido ranged from 0 to 25% (Table 1) as reported in this study. The further studies should be designed to investigate the pathogenic role of BIV in experimental infections with field isolates from Hokkaido under closely controlled conditions.
